U.S. Markets close in 5 hrs 34 mins

Cannabis Trends Have Medical Marijuana Stocks On Watch In 2019

CORAL GABLES, FL / ACCESSWIRE / December 13, 2018 / In the latest series of marijuana stock news the main focus has been on the 2018 US Farm Bill but what may be next is the focus on what is to come for 2019. David Goldstein, with the cannabis information company Potbotics, said 2018 was a ''huge year for marijuana. He said 2019 could be even bigger.''

"What I would like to see in 2019 is a de- schedulization," Goldstein said. "From a Schedule One drug that says marijuana has zero health benefits. To either a Schedule Two or a Schedule Three."

As focus turns to marijuana stocks in 2019, here are the cannabis companies to watch heading into the end of the year.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) has seen a week full of higher highs. On Monday, December 10, shares of the company opened the week at $0.62. As of December 12, Premier Health Group (OTC:PHGRF) (CSE:PHGI) hit highs of $0.80 during the morning session.

Premier Health Group (OTC:PHGRF) (CSE:PHGI) recently engaged discussions with Licensed Producers under the Access to Cannabis for Medical Purposes Regulation, other licensed medical cannabis companies and government officials in order to establish a framework for both patient and physician education.

Further to this, Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy. Premier Health Group (OTC:PHGRF) (CSE:PHGI) said that it expects the acquisition to close in or about Q1-19.

Dr. Essam Hamza, CEO of Premier Health Group (OTC:PHGRF) (CSE:PHGI) said, ''Premier has engaged with patients, pharmacies and technology providers to not only introduce pharmacy services as a component of our comprehensive telemedicine app, but also to explore and implement efficiencies in fill and fulfillment.''

Premier Health Group (OTC:PHGRF) (CSE:PHGI) has established a considerable patient roster as well. In comparison to some of the larger public marijuana companies, Premier Health Group (OTC:PHGRF) (CSE:PHGI)'s100,000+ patient pool is larger than that of Canopy Growth, which reported 84,400 registered patients at September 30, 2016. Furthermore, in its latest financial report, Aurora Cannabis for example, reported that it had 67,484 active registered patients and this was up from roughly 43,000 during the prior quarter.

For More Information On Premier Health Group, Click Here

Isodiol International Inc. (ISOLF) is focused on the development of CBD-based pharmaceuticals and CBD consumer products. BSPG Laboratories™, a subsidiary of Isodiol®, was recently registered with the United Kingdom's Medicines and Healthcare products Regulatory Agency for producing CBD as an active pharmaceutical ingredient for use in pharmaceutical applications for humans and animals.

The company recently announced the appointment of Mr. Trent Gray as channel manager of the Iso-Sport Golf Division. "To be able to effectively market the benefits of CBD performance products to golfers and develop meaningful relationships is something I'm definitely looking forward to," Gray said in a statement.

Isodiol CEO, Marcos Agramont stated, "We believe his unique skill set will provide added value to the division as we continue to seek new opportunities while growing our footprint within various sports markets."

Shares of Isodiol hit highs of $1.71 during open bell trade on Wednesday.

For More Information On Isodiol, Click Here

Cannabis Science, Inc. (OTC PINK: CBIS) takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory.

Earlier this quarter the company confirmed receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders, and Post-Traumatic Stress Disorders, among other target indications.

Shares of Cannabis Science traded higher on Thursday at a price of $0.0399, up from Wednesday's lows of $0.0321.

For More Information On Cannabis Science, Click Here

Aphria (NYSE: APHA: TSX: APHA) has traded higher this week. After a tumultuous week last week and lows of $3.75, shares of Aphria are trading above $5 this week.

Aphria most recently announced that it has signed a Letter of Intent with Insumos Medicos S.A., a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay.

"Latin America continues to represent an important growth opportunity within the global medical cannabis industry, and we are excited to be among the first to enter the rapidly emerging market in Paraguay," said Jakob Ripshtein, President of Aphria.

For More Information On Aphria, Click Here

About marijuanastocks.com

MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid ''500,000'' shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the ''500,000'' shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for our full disclaimer.

Contact Information:

pr@marijuanastocks.com

SOURCE: MarijuanaStocks.com